STOCK TITAN

COO Stephen Miller retiring from Medline (Nasdaq: MDLN) in 2026

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Medline Inc. disclosed that its Chief Operating Officer, Stephen L. Miller, has notified the company of his decision to retire for health-related reasons. The retirement will be effective August 30, 2026. Medline has begun a search for a successor to the COO role.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Retirement effective date August 30, 2026 Effective date of COO Stephen L. Miller’s retirement
Retirement notice date July 7, 2026 Date COO notified Medline of his retirement
Trading symbol MDLN Ticker for Medline’s Class A common stock on Nasdaq
Par value per share $0.0001 per share Par value of Medline Class A common stock
Form 8-K regulatory
"FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934"
A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.
Chief Operating Officer financial
"Stephen L. Miller, Chief Operating Officer of Medline Inc."
A chief operating officer (COO) is a senior executive responsible for overseeing the day-to-day activities of a company, ensuring that all parts of the organization work smoothly and efficiently. They often act like a company's operational quarterback, translating strategic plans into practical actions. For investors, the COO's effectiveness can influence a company's performance and stability, making them an important figure in assessing the company's management strength.
Nasdaq Stock Market LLC market
"Class A common stock ... MDLN ... Nasdaq Stock Market LLC"
Nasdaq Stock Market LLC is the company that operates the Nasdaq electronic stock exchange, a large centralized marketplace where shares of publicly traded companies are listed and bought and sold. Think of it as a high-speed digital auction house and storefront combined: being listed there gives a company visibility and easier access to many buyers, while investors benefit from transparent prices, fast trades and regulated rules that help protect fair trading.
Section 13 or 15(d) regulatory
"Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What leadership change did Medline (MDLN) announce in this 8-K?

Medline announced that Chief Operating Officer Stephen L. Miller will retire for health-related reasons, effective August 30, 2026. He notified the company of his decision on July 7, 2026, and Medline is starting a search for his successor.

When will Medline COO Stephen L. Miller’s retirement become effective?

Stephen L. Miller’s retirement from his role as Medline’s Chief Operating Officer becomes effective on August 30, 2026. He informed the company of his decision on July 7, 2026, giving several weeks for transition and succession planning.

Why is Medline COO Stephen L. Miller retiring according to the 8-K?

Medline states that Chief Operating Officer Stephen L. Miller is retiring for health-related reasons. The filing does not provide additional detail beyond this description but confirms his retirement date and that a search for his replacement has begun.

Is Medline (MDLN) searching for a replacement for its COO?

Yes, Medline reports it is launching a search for a successor to Chief Operating Officer Stephen L. Miller. This follows his notice on July 7, 2026 that he will retire effective August 30, 2026 for health-related reasons.

What SEC form did Medline file to report the COO’s retirement?

Medline filed a Form 8-K to report the planned retirement of Chief Operating Officer Stephen L. Miller. The disclosure appears under Item 5.02, which covers departures and appointments of directors and certain executive officers and related compensatory arrangements.

What stock exchange lists Medline (MDLN) and what class of stock is traded?

Medline’s Class A common stock, with a par value of $0.0001 per share, is listed on the Nasdaq Stock Market LLC under the trading symbol MDLN. This information is part of the company’s securities registration disclosure.
false 0002046386 0002046386 2026-07-07 2026-07-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 7, 2026

 

 

 

Medline Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 001-43022 33-1845288
(State or other jurisdiction of
incorporation)
(Commission File Number) (IRS Employer Identification Number)

 

3 Lakes Drive

Northfield, IL 60093

(Address of principal executive offices, including zip code)

 

(847) 949-5500

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which registered
Class A common stock, par value $0.0001 per share MDLN Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 7, 2026, Stephen L. Miller, Chief Operating Officer of Medline Inc. (the “Company”), notified the Company that he would retire from his role, effective August 30, 2026, for health-related reasons. The Company is launching a search for his successor.

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.

 

Date: July 9, 2026

 

  MEDLINE INC.
     
  By: /s/ Alex M. Liberman
    Name: Alex M. Liberman
    Title: Chief Legal Officer

 

 

Filing Exhibits & Attachments

3 documents